Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH)

Summary

This study is to evaluate the effect of rosuvastatin 10-20 mg on carotid atherosclerosis progression in Chinese patients by evaluating the change in the percentage of volume of lipid rich necrotic core (LRNC) using high-resolution magnetic resonance imaging (MRI) after 24-months treatment.

Timeline

Start

2009-03

Primary completion

2012-03

Completion

2012-03

Publications

• Du R, Cai J, Zhao XQ, Wang QJ, Liu DQ, Leng WX, Gao P, Wu HM, Ma L, Ye P. Early decrease in carotid plaque lipid content as assessed by magnetic resonance imaging during treatment of rosuvastatin. BMC Cardiovasc Disord. 2014 Jul 14;14:83. doi: 10.1186/1471-2261-14-83.

Drugs

Indications